1,435
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study

, ORCID Icon, &
Pages 731-737 | Received 01 May 2020, Accepted 23 Jun 2020, Published online: 23 Jul 2020

References

  • Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361–81. doi:10.1128/CMR.9.3.361.
  • Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014;2(2):39–55. doi:10.1177/2051013613515621.
  • Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis. 2003;188(9):1336‐1344. doi:10.1086/379048.
  • Wen SY, Liu WL. Epidemiology of pediatric herpes zoster after varicella infection: a population-based study. Pediatrics. 2015;135(3):e565–71. doi:10.1542/peds.2013-4037.
  • WHO World Health Organization. [accessd 2020 May 1]. https://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria[country][]=TUR.
  • WHO World Health Organization. Immunization summary. [accessed 2020 May 1]. http://apps.who.int/gho/data/node.main.PCV3n?lang=en.
  • Spackova M, Wiese-Posselt M, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in day-care centres [published correction appears in Vaccine. 2010 May 7;28(21):3754. Vaccine. 2010;28(3):686–91. doi:10.1016/j.vaccine.2009.10.086.
  • Vazquez M, LaRussa PS, Gershon AA, Niccolai LM, Muehlenbein CE, Steinberg SP, et al. Effectiveness over time of varicella vaccine. Jama. 2004;291(7):851–55. doi:10.1001/jama.291.7.851.
  • Mahamud A, Wiseman R, Grytdal S, Basham C, Ashgar J, Dang T, et al. Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine. 2012;30(48):6935–39. doi:10.1016/j.vaccine.2012.07.076.
  • Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, LaRussa PS, Gershon AA. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312–15. doi:10.1093/infdis/jiq052.
  • Varicella and herpes zoster vaccines: WHO position paper, June. Recommendations. WHO positions paper on vaccination against varicella and herpes. Vaccine. 2014;2016(34):198–99.
  • Hanquet G, Valenciano M, Simondon F, Moren A. Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine. 2013;31(48):5634–42. doi:10.1016/j.vaccine.2013.07.006.
  • Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-trejos A. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination. Expert Rev Vaccines. 2016;16(3):229–34. doi:10.1080/14760584.2017.1247700.
  • Garcia Cenoz M, Castilla J, Chamorro J, Martinez-Artola F, Irisarri F, Arriazu M, et al. Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro Surveill. 2013;18(32):20552. doi:10.2807/1560-7917.ES2013.18.32.20552.
  • Boccalini S, Bonanni P, Bechini A. Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004–2012. Euro Surveill. 2016;21(24). doi:10.2807/15607917.ES.2016.21.24.30257.
  • Baxter R, Tran TN, Ray P, Lewis E, Fireman B, Black S, Shinefield HR, Coplan PM, Saddier P. Impact of vaccination on the epidemiology of varicella: 1995–2009. Pediatrics. 2014;134(1):24–30. doi:10.1542/peds.2013-4251.
  • Schünemann S, Mainka C, Wolff MH. Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. Intervirology. 1998;41(2–3):98‐102. doi:10.1159/000024920.
  • Kozawa K, Miura H, Kawamura Y, Tanaka M, Kudo K, Higashimoto Y, et al. Frequency of subclinical herpes zoster in pediatric hematology-oncology patients receiving chemotherapy: A retrospective cohort analysis [published online ahead of print, 2019 Dec 10]. J Med Virol. 2019. doi:10.1002/jmv.25650.
  • Bonmarin I, Santa-Olalla P, Lévy-Bruhl D. Modelling the impact of vaccination on the epidemiology of varicella zoster virus. Rev Epidemiol Sante Publique. 2008;56(5):323–31. doi:10.1016/j.respe.2008.07.087.
  • Gao Z, Gidding HF, Wood JG, MacIntyre CR. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect. 2010;138(4):457–68. doi:10.1017/S0950268809990860.
  • Karhunen M, Leino T, Salo H, Davidkin I, Kilpi T, Auranen K. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect. 2010;138(4):469–81. doi:10.1017/S0950268809990768.
  • Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15:19530.
  • Quian J, Rüttimann R, Romero C, Dall’Orso P, Cerisola A, Breuer T, Greenberg M, Verstraeten T. Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Arch Dis Child. 2008;93(10):845–50. doi:10.1136/adc.2007.126243.
  • Giammanco G, Ciriminna S, Barberi I, Titone L, Lo Giudice M, Biasio LR. Universal varicella vaccination in the Sicilian paediatric population: rapid uptake of the vaccination programme and morbidity trends over five years. Euro Surveill. 2009;14:19321.
  • Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159(11):739–45. doi:10.7326/0003-4819-159-11-201312030-00006.
  • Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63(2):221–26. doi:10.1093/cid/ciw296.
  • Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52(3):332–40. doi:10.1093/cid/ciq077.
  • Harpaz R, Leung JW. The epidemiology of herpes zoster in the United States during the era of varicella and herpes zoster vaccines: changing patterns among older adults. Clin Infect Dis. 2019;69(2):341–44. doi:10.1093/cid/ciy953.
  • Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W. The impact of varicella vaccination on the incidence of varicella and Herpes Zoster in the United States: updated evidence from observational databases, 1991–2016. Clin Infect Dis. 2020 Mar 3;70(6):995–1002. doi:10.1093/cid/ciz305.
  • MacIntyre R, Stein A, Harrison C, Britt H, Mahimbo A, Cunningham A. Increasing trends of herpes zoster in Australia. PLoS One. 2015;10(4):e0125025. doi:10.1371/journal.pone.0125025.
  • Kelly HA, Grant KA, Gidding H, Carville KS. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Euro Surveill. 2014;19(41):20926. doi:10.2807/1560-7917.ES2014.19.41.20926.
  • Marra F, Chong M, Najafzadeh M. Increasing incidence associated with herpes zoster infection in British Columbia, Canada. BMC Infect Dis. 2016;16(1):589. doi:10.1186/s12879-016-1898-z.
  • Russell ML, Dover DC, Simmonds KA, Svenson LW. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014;32(47):6319–24. doi:10.1016/j.vaccine.2013.09.018.
  • Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10(12):3594–600. doi:10.4161/hv.34426.
  • Toyama N, Shiraki K. Miyazaki dermatologist society. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect. J Dermatol Sci. 2018;92(1):89–96. doi:10.1016/j.jdermsci.2018.07.003.
  • Choi J, Park S, Han K. The trend in the incidence of varicella and herpes zoster in Korea after implementation of universal 1-dose varicella vaccination, 2002–2015. 27th European Congress of Clinical Microbiology and Infectious Diseases; Vienna, Austria; 2017.
  • Esteban-Vasallo MD, Gil-Prieto R, Dominguez-Berjon MF, Astray-Mojales Y, Gil de Miguel A. Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005–2012. J Infect. 2014;68(4):378–86. doi:10.1016/j.jinf.2013.09.035.
  • Wu PY, Wu HD, Chou TC, Sung FC. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One. 2013;8(10):e77709. doi:10.1371/journal.pone.0077709.
  • Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
  • Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine. 2013;31(42):4744–48. doi:10.1016/j.vaccine.2013.08.022.
  • Gidding HF, Brisson M, Macintyre CR, Burgess MA. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health. 2005;29(6):544–51. doi:10.1111/j.1467-842X.2005.tb00248.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.